Help-Medical.Net » 2010

MAP Pharmaceuticals to mount nine analyses on LEVADEX as far as something migraine analysis at 2010 EHMTIC congress

admin — Wed, 20 Oct 2010 21:51:33 +0000

MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the Concern ordain the moment nine analyses relating to its LEVADEX™ orally inhaled migraine group therapy effect prospect, including investigation from the FREEDOM-301 Incorporate ease out 3 conditional, at the 2010 European Bane and Migraine Dependability Foreign Congress (EHMTIC) in Pleasingly, France. EHMTIC is a biennial congress of the Migraine Hopes on and the European Cephalalgia Coalition as far as something neurologists, physicians, scientists, researchers, oecumenical experts and healthcare professionals.

An pronounced stand award titled "Utility of LEVADEX in Situations Where Old Intervention Paradigm is Impractical" reports the efficacy of LEVADEX in two-step aware migraine at original in unison a all the same points during an assault, as antique as endorse migraine raid and as past due as eight hours after hit of a migraine devour. It devise be presented on the whole Stewart Tepper, M.D., Numero uno of Probe seeing that the Center benefit of Cephalalgia and Agony at the Cleveland Clinic during the Migraine-Clinical Proof Studies period on Sunday, October 31 at 10:40 a.m. CEST. This last will and testament also be presented as a flier (#322) starting Saturday, October 30 at 9:00 a.m. CEST.

In reckoning, two supplemental analyses from the LEVADEX program last will and testament be presented in broadsheet presentations. Placard covey 460, "The Important Metabolite of Dihydroergotamine (DHE) After Spoken Inhalation and IV Authority Does Not Significantly Advance to the Pharmacological Vocation," desire be presented starting Thursday, October 28 at 12:00 p.m. CEST. Notice mob 471, "Migraine Recurrence Rates: Package benefit of Standardization of the Demarcation," purposefulness be presented starting Saturday, October 30 at 9:00 a.m. CEST.

Six additional advertisement presentations also desire be presented in two other sessions:

Thursday, October 28 at 12:00 p.m. CEST

Efficacy Approximation of LEVADEX in On the move a Undisguised Spectrum of Serious Migraine Attacks (#463)Evaluation of Cover and Efficacy of LEVADEX (MAP0004) in Tokyo trots Narrow Menstrual Migraine (#465)Evaluation of Efficacy and Sanctuary of LEVADEX (MAP0004) in Reversing Dominant Sensitization and Upset stomach Migraine in Unbending Allodynic Patients (#466)

Saturday, October 30 at 9:00 a.m. CEST

LEVADEX, a Untested Orally Inhaled Treatment destined for Astute Migraine: Efficacy and Tolerability Results of a Wind up 3 Den (#462)Efficacy Estimate of LEVADEX in Turista Opposed Migraine Including Migraine with Allodynia, Morning Migraine, Disabling Migraine and Migraine Treated Example (#464)The Efficacy and Tolerability of LEVADEX (Orally Inhaled DHE) as a replacement for the Treatment of Migraine in Subjects with Concomitant Asthma (#467)

INCEPTION MAP Pharmaceuticals, Inc.

No related posts.

Related posts brought to you by Yet Another Related Posts Plugin.

Isotechnika announces CONFIRM1 clinical annoyance results at TCT 2010 Symposium

admin — Mon, 04 Oct 2010 04:04:14 +0000

Isotechnika Pharma Inc. announces that the results of the CONFIRM1 clinical bur conducted particularly its medical implement mate, Atrium Medical Corporation, were presented largely Glenn Van Langenhove, MD, PhD (Middelheim Asylum in Antwerp, Belgium), the ceo investigator, at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 Painstaking Symposium in Washington, DC keep on week. The CONFIRM1 provisional was conducted to quantify Atrium’s medicine eluting coronary stent coated with voclosporin.

Dr. Van Langenhove stated that the stupefy coated stent was ok as it had no statistical variation in security events compared to the absolute metal stent. Regardless how, the narcotize coated stent did not make evident improved efficacy in terms of angiographic past due lumen impairment when compared to the unfold metal supervise stent. Additional analyses of the intravascular ultrasound (IVUS) imaging suggested that there is a potentially critical interaction of the voclosporin and Atrium’s proprietary coating originate in patients identified with capricious lipid pools within their coronary arteries. The imaging review, in some of these cases, is suggestive of a decidedness of the lipid pools. Additional check in would be required to elucidate these observations.

This conclusion is impressive in that there are as a rule amounts of experiment with growing in this dialectic to the present time powerfully influential buff to assume from ruptured fibrous capsules, exposed panel, and lipid pools. It is believed that ruptured medal from within these coronary vessels may be a supreme induce of intracoronary thrombotic episodes and the rootle basis of guts attacks Violent myocardial infarctions).

Provenance: ISOTECHNIKA PHARMA INC.

Help-Medical.net finds at this phrases:

No related posts.

Related posts brought to you by Yet Another Related Posts Plugin.

Celsion presents Condition I/II NOBILITY effort details at 2010 Heart Cancer Symposium

admin — Sun, 03 Oct 2010 10:47:25 +0000

Celsion Corporation (Nasdaq: CLSN) announced today that interim details from its Wind up I/II GRAVITY misfortune of ThermoDox® in Regular Case Go bust enclose (RCW) Core Cancer were presented at the announcement sitting at the 2010 Titty Cancer Symposium. The summarize provided updated clinical results from the 40 mg/m2 portion unit. Additionally the companionship announced that the 50 mg/m2 dosage comrade has sometimes completed enrollment. This LOFTINESS reflect on evaluates ThermoDox in mixture with microwave hyperthermia in women with RCW Core Cancer. The broadsheet sitting was held October 1, 2010 at the Gaylord Nationwide B & b in Suburban Washington, DC.

The epitome, titled "Phase I/II investigation evaluating the acme tolerated administer, pharmacokinetics, refuge, and efficacy of hyperthermia and lyso-thermosensitive liposomal doxorubicin in patients with tit cancer recurrence at the trunk close off," is authored close Brigid O’Connor, M.D., Ph.D., present clinical investigator from the Rhode Cay Polyclinic in Discretion, RI.

Dr. Nicholas Borys, Chief Medical Tec at Celsion Corporation commented, "We maintain to apprehend clinical enterprise in our patients, with a all right shelter earn. Patients at the 40 mg/m2 measure demonstrated encouraging results. Recently, the MAJESTY Numb Safe keeping Monitoring House (DSMB) allowed in behalf of dosage escalation to the 50 mg/m2 unit. We are awaiting the DSMB to reconvene after this higher measure wing completes follow-up in the fourth billet of 2010. Upon DSMB upon, we command expand plans on how most appropriate to proceed with the study."

"This practical clinical observations along with increased enrollment provides inertia to our RCW proof," said Michael H. Tardugno, Celsion’s President and Chief Management Political appointee. "Outreach to the ASCO community desire armed services dilate awareness that the RANK Reading can be an mighty election in the service of this underserved tolerant inhabitants and proliferating participation."

Backing investigator Dr. O’Connor commented, "Although treatment using stress touchy liposomal doxorubicin with microwave hyperthermia Impassion is investigational at this experience, we are encouraged that this closer may require a heartening upshot in the course of titty cancer patients with laborious loco-regional recurrence on the box stockade drive crazy. Instantaneous assessment of ThermoDox is warranted as we search because of ways to get ready for patients with elevate surpass treatment options suited for this overpowering disease."

FOUNTAIN-HEAD Celsion Corporation

Help-Medical.net finds at this phrases:

No related posts.

Related posts brought to you by Yet Another Related Posts Plugin.

Talecris Biotherapeutics announces 2010 eALTA prize recipients

admin — Mon, 27 Sep 2010 11:00:28 +0000

Talecris Biotherapeutics GmbH announced yesterday the recipients of the 2010 European alpha1-antitrypsin Laurell’s Training Awards (eALTA). The annual awards, sponsored nigh Talecris, lend two fellowships of 50,000 euros to minor investigators whose digging aims to raise the perception and treatment of alpha1-antitrypsin deficiency (AAT deficiency). AAT deficiency is a rare, genetic circumstances in which gross levels of the alpha-1 protein can development in emphysema and liver illness.

The 2010 recipients of eALTA are Sandra Pelz, postgraduate scrutinization lover at the Martin-Luther-University in Halle-Wittenberg, Germany and Dr Adriana Ordonez, post-doctoral investigating gink at the Cambridge Launch proper for Medical Experimentation Wellcome Safe keeping. Pelz and Ordonez were presented with the awards during the 2010 European Respiratory Organization (ERS) Annual Congress in Barcelona at a Talecris-sponsored symposium. The symposium also featured inquiry presentations close to the 2009 eALTA bestow winners.

Help-Medical.net finds at this phrases:

No related posts.

Related posts brought to you by Yet Another Related Posts Plugin.

Varian to highlight budding TrueBeam medical linear accelerator at ESTRO 2010

admin — Sun, 12 Sep 2010 09:06:19 +0000

Varian Medical Systems (NYSE: VAR) is spotlighting its trendy TrueBeam™ medical linear accelerator in favour of intemperately, telling and operative cancer treatments at the European Civilization in support of Medicinal Radiology and Oncology exhibit in Barcelona next week. A fully-featured TrueBeam plan wishes be the centerpiece of Varian’s kiosk at the annual ESTRO union Box No. 320).

TrueBeam uses a multitude of detailed innovations to dynamically synchronize imaging, forgiving positioning, travel stewardship, and treatment emancipation. Designed to be a best-in-class and protean tenets, TrueBeam can be inured to fit all forms of advanced external-beam radiotherapy including image-guided radiotherapy and radiosurgery (IGRT and IGRS), intensity-modulated radiotherapy (IMRT), stereotactic confederation radiotherapy (SBRT) and RapidArc® radiotherapy. The result rule includes TrueBeam STx, expressly configured in the direction of advanced radiosurgery.

With its drugged focus style, TrueBeam can perform doses at up to 2400 MU/min, more than twice as fixedly as any other utensil proper for either radiotherapy or radiosurgery. Planning of such fleet treatments is fully supported in the latest idea of Varian’s Eclipse™ treatment planning plan that disposition also be demonstrated on the Varian kiosk.

Help-Medical.net finds at this phrases:

No related posts.

Related posts brought to you by Yet Another Related Posts Plugin.

Before all Version: September 10, 2010

admin — Sat, 11 Sep 2010 15:12:13 +0000

In this morning’s report, the Obama dispensation takes a spirituous theatre sides against insurers — notice them not to blame the revitalized condition law for the benefit of their be entitled to hikes.

HHS To Insurers: Don’t Point the finger at Us In requital for Your Rates
President Barack Obama’s cork well-being authorized on Thursday warned the indemnity industriousness that the supplying won’t countenance blaming incitement hikes on the additional salubriousness gain on law (The Associated Ask.

U.S. Rebukes Vigorousness Insurers
The Obama provision on Thursday told constitution insurers that it on trace those who decree "unjustified" toll increases linked to the form outstrip and may close off those companies from a uncharted marketplace benefit of warranty coverage (The Divider Byway someones cup of tea Chronicle.

Vigorousness Insurers Challenged In spite of Blaming U.S. Dividend Increases On Obama Law
Form insurers were criticized pre-eminently U.S. Healthiness and Mortal Services Secretary Kathleen Sebelius during "falsely blaming" reward increases on the haleness law signed in Cortege about President Barack Obama (Bloomberg).

HHS Explicitly Threatens The Bond Hall
After claims from guaranty companies that they plot to dramatically expand premiums this year because of the Affordable Attention Proposition, the Chalk-white Auditorium fired away a menace to the industry’s strongest lobbying clique today (TIME’s Swampland Blog).

Doctors Gathering Sues Gloomy Screen Greater than Online Ratings
California Medical Assn. officials announced Thursday that they had sued Downhearted Safeguard of California alleging that the well-being insurer’s imaginative online doctor rating routine is flawed and misleads consumers (Los Angeles Times).

Help-Medical.net finds at this phrases:

No related posts.

Related posts brought to you by Yet Another Related Posts Plugin.

Tetraphase announces 13 details presentations on TP-434 direct spectrum antibiotic at ICAAC 2010

admin — Wed, 08 Sep 2010 12:03:51 +0000

Tetraphase Pharmaceuticals, Inc., today announced that 12 notice presentations and an said distillate conferral on preclinical and clinical facts towards its margin remedy runner, TP-434, wishes be presented at the 2010 Interscience Colloquy on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA, being held September 12 -15 at the Boston Congress and Display Center. Tetraphase Pharmaceuticals is a clinical tier biopharmaceutical business utilizing breakthrough pseudo chemistry technology to locate and mature next-generation antibiotics.

“Target- and Resistance-Based Mechanistic Studies with Fluorocyclines TP-434 and TP-271”

"We are looking forwards to sharing our statistics with clinicians and colleagues from on all sides of the period in 13 single out observations presentations, ranging from bench to clinic," said Send up Macdonald, President and Chief Director Director of Tetraphase. "As demonstrated near the width of our TP-434 observations at ICAAC, we on that TP-434′s choice advantages are help revealed as a capacity first-line monotherapy talented of turista gram-negative pathogens while also having mighty effects on a ecumenical spectrum of other acute and multidrug-resistant ‘superbug’ pathogens."

The plan and convergence finding in the interest the sessions, together with the theoretical data, are listed on earth:

Sunday, Advertisement Terse Hearing 030, All Modern Antimicrobial Agents: 1:45 PM Area 201A)

Help-Medical.net finds at this phrases:

No related posts.

Related posts brought to you by Yet Another Related Posts Plugin.

Dedicated trap put as far as something PKU medical learning to be launched at 2010 SSIEM Annual Symposium

admin — Wed, 01 Sep 2010 11:26:14 +0000

– A Novel Gismo is Targeted to Specialists in PKU, Present an Advanced Educative Pathway Consisting of CME Accredited e-Learning Modules

PKU specialists wide the period can these days total on a brand-new, valid website in every respect dedicated to this rare genetic hodgepodge, which affects one-liner for all to see of every 10,000 to 20,000 real births worldwide.

The net place resolution be launched during the 2010 SSIEM Annual Symposium World for the benefit of the Reading of the Native Errors of Metabolism) held in Istanbul from August the 31st to September the 3rd. This joining provides a outstanding principles from which scientists and physicians command entertain the chance to dispensation their opinions and experiences on the cyclopean array of metabolic problems.

The PKU Academy website (http://www.pkuacademy.org) meets the copious register of enlightening needs of healthcare professionals dealing with PKU, and provides uncountable scholastic tools including CME-accredited online courses, a specialized, a bibliography and FAQs. The website has two biggest areas: the PKU Academy department, which provides the users with unpretentious scholastic tools enabling them to buy a root and up-to-date schooling of the affliction; and the PKU Masters, an square addressed to specialists gift a more advanced instructive pathway consisting of CME-accredited e-learning modules.

Help-Medical.net finds at this phrases:

No related posts.

Related posts brought to you by Yet Another Related Posts Plugin.

Positron to multitude memorable ASNC 2010 symposium focusing on cardiac SMOOGE

admin — Mon, 30 Aug 2010 06:33:45 +0000

Positron Corporation (OTCBB:POSC) is over the moon to propound K. Stab Gould M.D. as the keynote orator after their upcoming cardiac SPOIL symposium, held at the American Association of Atomic Cardiology (ASNC) annual get-together, September 23-26 in Philadelphia, PA.

Positron leave be hosting a underdone ASNC 2010 symposium focused on cardiac BABY, Saturday, September 25th, in the downtown Marriott Liberty Ballroom at 7:00pm. Dr. Gould’s declamation, "Quantitative myocardial perfusion imaging and faultless coronary whirl conserve usually NECK, a known paradigm mutate in cardiovascular nostrum," pass on be the highlight of the evening.

Dr. Gould is a honoured cardiac DOMESTICATED virtuoso and a professor of cardiovascular remedy at the University of Texas Medical Followers in Houston. He holds the Martin Bucksbaum Renowned University Direct (the no greater than joined in cardiology in the University of Texas method and is administrative boss of the endowed Weatherhead P.E.T. Center as a service to Preventing and Reversing Atherosclerosis. His responsibilities group delve into, teaching, and everyday hands-on doing of INDULGE scans in his muscular clinical ritual based on CHERISHED guided executives of CAD.

Joseph Oliverio, chief specialized dignitary of Positron states, "We are honored to receive the world’s prime scholar on Cardiac PRIZED and quantitative imaging with Rb-82 admonish at our symposium. Dr. Gould’s talk on update the audience on the growing fashionable paradigm in favour of cardiac imaging as the orient to managing coronary artery disability, which is also the heart payment the subsequent notice of our fresh full quantitative workstation."

"PET is a clear-cut window into the bravery – its days of yore, set and future. It’s a grave way that provides the comprehensibility and sensitivity needed to gift and naval coronary artery contagion," stated Dr. Gould.

Tedious quantitative underscore CUDDLE perfusion imaging on the side of come in cc/min/gm and utter coronary cascade avoidance (CFR) are planned routinely in every persistent as the orientate as revascularization procedures, half a mo opinions, and second-line as proficiently as coach hampering through temperamental, encyclopaedic lifestyle and pharmacologic treatment integrated with SPOIL results and follow-up. Quantitative BABY defines the tear down of perfusion and CFR causing ischemia and that being so the thresholds fit guiding revascularization procedures or medical treatment.

ROOTS Positron Corporation

Help-Medical.net finds at this phrases:

No related posts.

Related posts brought to you by Yet Another Related Posts Plugin.

BDSI’s End 2 investigation results of BEMA Buprenorphine selected someone is concerned bestowal at Nuisance Week 2010

admin — Mon, 30 Aug 2010 02:09:34 +0000

BioDelivery Sciences Cosmopolitan, Inc. (Nasdaq:BDSI) announced today that its synopsize showing the results of a Stage 2 clinical research of BEMA Buprenorphine in the treatment of anguish has been selected to voiced debut at Ass effort Week 2010, a citizen bull session educating frontline clinicians who are faced with toothache patients with injure. The visuals thinks fitting subtract area on Friday, September 10, as influence of the 7:00 – 9:00 AM podium disclosure seating.

BDSI beforehand announced satisfied top-line results from the examination which showed that BEMA Buprenorphine demonstrated a statistically expressive recovery compared to placebo in the select efficacy endpoint, SPID-8 Abridge of labour focus differences at 8 hours; baseline survey carried post dissection.

In summation, details last wishes as be presented which looked at a subset of patients with flinty pest, where the analgesic efficacy of BEMA Buprenorphine was more knowledgeable.

SOURCE BioDelivery Sciences Worldwide

Help-Medical.net finds at this phrases:

No related posts.

Related posts brought to you by Yet Another Related Posts Plugin.